Deal profile | Gadens advises Ryman Healthcare on secondary listing on ASX

Gadens has advised Ryman Healthcare, New Zealand’s largest aged care and retirement living provider, on its successful secondary listing on the Australian Securities Exchange (ASX) with a market capitalisation upon listing of approximately A$2.5 billion.

This secondary listing will complement Ryman Healthcare’s existing NZX listing and is designed to broaden its investor base and enhance share liquidity through ASX, a premium market with a long track record as a platform for global healthcare companies. The listing also aligns with Ryman Healthcare’s significant operational footprint in Australia, which now includes multiple large-scale retirement villages and aged care facilities.

This transaction reinforces Ryman Healthcare’s long-term commitment to the Australian market and positions it for future capital markets engagement.

Gadens has a long-standing relationship advising Ryman Healthcare on sales and acquisitions as part of its investment and expansion strategy for Australia.

Practice groups: Corporate

Key team members: Corporate Partner Michael Kenny lead on the transaction, supported by Special Counsel Gary Lim and Lawyer Adele Elia.